Literature DB >> 20642682

Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.

C C Lin1, M Ezzelarab, R Shapiro, B Ekser, C Long, H Hara, G Echeverri, C Torres, H Watanabe, D Ayares, A Dorling, D K C Cooper.   

Abstract

Consumptive coagulopathy (CC) remains a challenge in pig-to-primate organ xenotransplantation (Tx). This study investigated the role of tissue factor (TF) expression on circulating platelets and peripheral blood mononuclear cells (PBMCs). Baboons (n = 9) received a kidney graft from pigs that were either wild-type (n = 2), alpha1,3-galactosyltransferase gene-knockout (GT-KO; n = 1) or GT-KO and transgenic for the complement-regulatory protein, CD46 (GT-KO/CD46, n = 6). In the baboon where the graft developed hyperacute rejection (n = 1), the platelets and PBMCs expressed TF within 4 h of Tx. In the remaining baboons, TF was detected on platelets on post-Tx day 1. Subsequently, platelet-leukocyte aggregation developed with formation of thrombin. In the six baboons with CC, TF was not detected on baboon PBMCs until CC was beginning to develop. Graft histopathology showed fibrin deposition and platelet aggregation (n = 6), but with only minor or no features indicating a humoral immune response (n = 3), and no macrophage, B or T cell infiltration (n = 6). Activation of platelets to express TF was associated with the initiation of CC, whereas TF expression on PBMCs was concomitant with the onset of CC, often in the relative absence of features of acute humoral xenograft rejection. Prevention of recipient platelet activation may be crucial for successful pig-to-primate kidney Tx.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642682      PMCID: PMC2914318          DOI: 10.1111/j.1600-6143.2010.03147.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  43 in total

1.  Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.

Authors:  T Kawai; D Andrews; R B Colvin; D H Sachs; A B Cosimi
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Tissue-specific hemostasis: role of tissue factor.

Authors:  N Mackman
Journal:  J Thromb Haemost       Date:  2007-12-13       Impact factor: 5.824

Review 3.  Platelet-lymphocyte cross-talk.

Authors:  Nailin Li
Journal:  J Leukoc Biol       Date:  2008-01-15       Impact factor: 4.962

4.  Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.

Authors:  Patricia Redecha; Claus-Werner Franzke; Wolfram Ruf; Nigel Mackman; Guillermina Girardi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

5.  Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

Authors:  Grace M Thomas; Laurence Panicot-Dubois; Romaric Lacroix; Françoise Dignat-George; Dominique Lombardo; Christophe Dubois
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

6.  In vitro investigation of pig cells for resistance to human antibody-mediated rejection.

Authors:  Hidetaka Hara; Cassandra Long; Yih Jyh Lin; Hao-Chih Tai; Mohamed Ezzelarab; David Ayares; David K C Cooper
Journal:  Transpl Int       Date:  2008-09-01       Impact factor: 3.782

Review 7.  Inflammation, endothelium, and coagulation in sepsis.

Authors:  Marcel Schouten; Willem Joost Wiersinga; Marcel Levi; Tom van der Poll
Journal:  J Leukoc Biol       Date:  2007-11-21       Impact factor: 4.962

8.  Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.

Authors:  Chih Che Lin; Daxin Chen; John H McVey; David K C Cooper; Anthony Dorling
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

Review 9.  [Haemostatic aspects in clinical oncology].

Authors:  F Langer; K Holstein; B Eifrig; C Bokemeyer
Journal:  Hamostaseologie       Date:  2008-12       Impact factor: 1.778

10.  The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients.

Authors:  Mohamed Ezzelarab; Bertha Garcia; Agnes Azimzadeh; Hongtao Sun; Chih Che Lin; Hidetaka Hara; Sean Kelishadi; Tianshu Zhang; Yih Jyh Lin; Hao-Chi Tai; Robert Wagner; Jnanesh Thacker; Noriko Murase; Kenneth McCurry; Rolf N Barth; David Ayares; Richard N Pierson; David K C Cooper
Journal:  Transplantation       Date:  2009-03-27       Impact factor: 4.939

View more
  44 in total

1.  Further evidence for sustained systemic inflammation in xenograft recipients (SIXR).

Authors:  Hayato Iwase; Burcin Ekser; Huidong Zhou; Hong Liu; Vikas Satyananda; Rishab Humar; Pooja Humar; Hidetaka Hara; Cassandra Long; Jay K Bhama; Pietro Bajona; Yi Wang; Martin Wijkstrom; David Ayares; Mohamed B Ezzelarab; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-08-21       Impact factor: 3.907

Review 2.  Clinical lung xenotransplantation--what donor genetic modifications may be necessary?

Authors:  David K C Cooper; Burcin Ekser; Christopher Burlak; Mohamed Ezzelarab; Hidetaka Hara; Leela Paris; A Joseph Tector; Carol Phelps; Agnes M Azimzadeh; David Ayares; Simon C Robson; Richard N Pierson
Journal:  Xenotransplantation       Date:  2012 May-Jun       Impact factor: 3.907

3.  Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells.

Authors:  Corin Ezzelarab; David Ayares; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2012-09-13       Impact factor: 3.907

Review 4.  Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates.

Authors:  Burcin Ekser; Goutham Kumar; Massimiliano Veroux; David K C Cooper
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

5.  Targeting complement component 5a promotes vascular integrity and limits airway remodeling.

Authors:  Mohammad A Khan; Christian Maasch; Axel Vater; Sven Klussmann; John Morser; Lawrence L Leung; Carl Atkinson; Stephen Tomlinson; Peter S Heeger; Mark R Nicolls
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

6.  Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.

Authors:  Hayato Iwase; Burcin Ekser; Hao Zhou; Eefje M Dons; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

Review 7.  Immunobiological barriers to xenotransplantation.

Authors:  David K C Cooper; Burcin Ekser; A Joseph Tector
Journal:  Int J Surg       Date:  2015-07-06       Impact factor: 6.071

Review 8.  Immunobiology of liver xenotransplantation.

Authors:  Burcin Ekser; Christopher Burlak; Joshua P Waldman; Andrew J Lutz; Leela L Paris; Massimiliano Veroux; Simon C Robson; Michael A Rees; David Ayares; Bruno Gridelli; A Joseph Tector; David Kc Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

9.  Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Robert F Hoyt; Marvin L Thomas; David Ayares; Keith A Horvath
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-06       Impact factor: 5.209

Review 10.  Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature.

Authors:  David K C Cooper; Vikas Satyananda; Burcin Ekser; Dirk J van der Windt; Hidetaka Hara; Mohamed B Ezzelarab; Henk-Jan Schuurman
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.